210 related articles for article (PubMed ID: 19139106)
1. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
Winkler M; Lutz R; Russ U; Quast U; Bryan J
J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
[TBL] [Abstract][Full Text] [Related]
2. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
Proks P; Antcliff JF; Lippiat J; Gloyn AL; Hattersley AT; Ashcroft FM
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17539-44. PubMed ID: 15583126
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of KATP hyperactivity and sulfonylurea tolerance due to a diabetogenic mutation in L0 helix of sulfonylurea receptor 1 (ABCC8).
Babenko AP; Vaxillaire M
FEBS Lett; 2011 Nov; 585(22):3555-9. PubMed ID: 22020219
[TBL] [Abstract][Full Text] [Related]
5. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
de Wet H; Rees MG; Shimomura K; Aittoniemi J; Patch AM; Flanagan SE; Ellard S; Hattersley AT; Sansom MS; Ashcroft FM
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18988-92. PubMed ID: 18025464
[TBL] [Abstract][Full Text] [Related]
6. N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.
Pratt EB; Tewson P; Bruederle CE; Skach WR; Shyng SL
J Gen Physiol; 2011 Mar; 137(3):299-314. PubMed ID: 21321069
[TBL] [Abstract][Full Text] [Related]
7. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
Tammaro P; Ashcroft F
J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
[TBL] [Abstract][Full Text] [Related]
8. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
[TBL] [Abstract][Full Text] [Related]
9. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
[TBL] [Abstract][Full Text] [Related]
10. Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.
Zhou Q; Garin I; Castaño L; Argente J; Muñoz-Calvo MT; Perez de Nanclares G; Shyng SL
J Clin Endocrinol Metab; 2010 Dec; 95(12):E473-8. PubMed ID: 20810569
[TBL] [Abstract][Full Text] [Related]
11. ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K
Sikimic J; McMillen TS; Bleile C; Dastvan F; Quast U; Krippeit-Drews P; Drews G; Bryan J
J Biol Chem; 2019 Mar; 294(10):3707-3719. PubMed ID: 30587573
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
[TBL] [Abstract][Full Text] [Related]
13. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
Edghill EL; Flanagan SE; Ellard S
Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570
[TBL] [Abstract][Full Text] [Related]
14. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
[TBL] [Abstract][Full Text] [Related]
15. Activation of the K(ATP) channel by Mg-nucleotide interaction with SUR1.
Proks P; de Wet H; Ashcroft FM
J Gen Physiol; 2010 Oct; 136(4):389-405. PubMed ID: 20876358
[TBL] [Abstract][Full Text] [Related]
16. Engineered interaction between SUR1 and Kir6.2 that enhances ATP sensitivity in KATP channels.
Pratt EB; Zhou Q; Gay JW; Shyng SL
J Gen Physiol; 2012 Aug; 140(2):175-87. PubMed ID: 22802363
[TBL] [Abstract][Full Text] [Related]
17. An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
Craig TJ; Shimomura K; Holl RW; Flanagan SE; Ellard S; Ashcroft FM
J Clin Endocrinol Metab; 2009 Jul; 94(7):2551-7. PubMed ID: 19351728
[TBL] [Abstract][Full Text] [Related]
18. Compound heterozygous mutations in the SUR1 (ABCC 8) subunit of pancreatic K(ATP) channels cause neonatal diabetes by perturbing the coupling between Kir6.2 and SUR1 subunits.
Lin YW; Akrouh A; Hsu Y; Hughes N; Nichols CG; De León DD
Channels (Austin); 2012; 6(2):133-8. PubMed ID: 22562119
[TBL] [Abstract][Full Text] [Related]
19. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
20. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
Hosy E; Dérand R; Revilloud J; Vivaudou M
J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
